Epoch Biodesign
Updated: April 01, 2026
CEO - Jacob Nathan
Country: UK | Funding: $47.3M (+)
Founded: 2019
Website: https://www.epochbiodesign.com/
Epoch aims to commercially scale its nylon recycling technology - enzymes that transform plastics into circular chemicals. The company operates demonstration-scale facility located near Imperial College London and plans to bring a commercial-scale facility online in 2028, which will have the capacity to produce 20,000 metric tons of monomer - small, basic molecules that act as the building blocks for plastic - annually
Founded: 2019
Website: https://www.epochbiodesign.com/
Epoch aims to commercially scale its nylon recycling technology - enzymes that transform plastics into circular chemicals. The company operates demonstration-scale facility located near Imperial College London and plans to bring a commercial-scale facility online in 2028, which will have the capacity to produce 20,000 metric tons of monomer - small, basic molecules that act as the building blocks for plastic - annually
